Testing effectiveness (Phase 2)Study completedNCT02703779
What this trial is testing
Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
Who this might be right for
Multiple Myeloma
Siddhartha Ganguly 101